Introduction
The coordinated function of reproductive organs is regulated systemically by the controlled release of various hormones. The response of a target tissue to these hormones can be modified by local factors which have autocrine or paracrine effects. Much attention has been focused on the hormones and factors that act on, or are produced by, reproductive cells, such as the steroidogenic cells in the ovary. More recently, it has been appreciated that reproductive tissues are composed of a heterogeneous population of cells, which may be involved in modulating the activity of the relevant reproductive cell type. The function of steroidogenic cells may be altered by endothelial cells and fibroblasts, through secretion of growth factors or by direct cell-cell contacts. In many tissues, resident immune cells may also have a role in the regulation of that tissue. Haematopoietic cells are found in the extravascular tissue of the ovary, uterus and testis (Hill and Anderson, 1990) . The products of these cells, termed cytokines, have been localized in uterine and trophoblastic tissues (Hunt et al., 1992 (Hunt et al., , 1993 , and may be involved in embryonic-uterine signalling at the Lime of implantation. The effects of one cytokine, interleukin-1 (IL-1), on hypothalamic-pituitary function are well documented (Sapolsky et al., 1987) . This review will focus on immune cells and cytokine actions in the ovary, with emphasis on the corpus luteum, particularly luteal regression. The reader is referred to other recent reviews on this subject (Pate, 1994; Pate and Townson, 1994) .
Immune Cells and Their Products
Leukocytic cells which coordinate and carry out specific immune responses can be generally classified into three categories. Macrophages are phagocytic cells that process proteins to be presented to T cells, and serve as early activators of the immune response. In humoral immune responses, B cells, which are antibody-producing cells, can also present antigens to T cells. T cells are antigen-restricted cells: differentiation and proliferation of these cells occur only in response to recognition of antigenic peptide which is presented in association with a major histocompatibility (MHC) molecule on the cell surface. Cytotoxic T cells (TO recognize antigens in association with MHC class I molecules, and when activated, cause direct damage to cell membranes leading to cytolysis. MHC class II molecules are recognized by T helper (TH) cells, which then secrete a variety of cytokines that activate B cells or Tc cells. Subclasses of TH cells can be recognized on the basis of the cytokines that they secrete. Cells of the TH1 subclass produce IL-2, gamma-interferon (IFN-y) and tumour necrosis factor (TNF (Cavender and Murdoch, 1988; Standaert et al., 1990) . T cells are also present in follicle walls of rats and humans; however, there are fewer T cells than macrophages (Brannstrom and Norman, 1993) . Both macrophages and lymphocytes are present in corpora lutea throughout the luteal phase (Lobel and Levy, 1968; Brannstrom et al., 1994a) . In the rabbit corpus luteum, the number of lymphocytes remains constant, but the number of macrophages increases before the onset of luteolysis (Bagavandoss et al., 1988 ). An early study in cows showed that fewer immune cells infiltrate the corpus luteum during early pregnancy than in the nonfertile cycle (Lobel and Levy, 1968) . Cytokines are soluble proteins which have been primarily viewed as autocrine or paracrine factors acting within the immune system. However, it is now recognized that some of the cytokines are also produced by, and can act on, non-immune cells. The cytokines that have been implicated in ovarian function are IL-I, IL-2, TNF-a, IFN-y, IFN-a arid granulocyte-macrophage colony-stimulating factor (GM-CSF).
Actions of Cytokines in the Ovary
Before purified or recombinant cytokines were available, it was recognized that progesterone production by granulosa cells could be altered by leukocyte secretions. Lymphocyte-conditioned medium stimulates progesterone production by cultured rat and human granulosa cells (Hughes et al., 1991; Emi et aL, 1991) .
Co-culture of lymphocytes with pig granulosa cells results in enhanced progesterone secretion if the granulosa cells are derived from large, but not from small, follicles. However, monocytes stimulate progesterone production by granulosa cells from both small and large follicles (Standaert et al., 1990) . However, it is not possible to determine from these studies whether the effects were due to actions of cytokines or other secreted products, such as prostaglandins, growth factors, or gonadotrophin-like substances.
The effects of purified preparations of specific cytokines on follicular cells tend to be inhibitory, although this may depend on the state of differentiation of the granulosa cells. In most studies, FSH-stimulated steroidogenesis and induction of LH receptors was inhibited by IL-113, TNF-a or IFN-y (Gottschall et al., 1987; Gorospe et al., 1988; Darbon et al., 1989; Roby and Terranova, 1990) . In pig granulosa cells collected from small follicles, FSH-stimulated oestradiol production is inhibited by IL-13, IL-2, IL-6, TNF-a, IFN-y and IFN-a, whereas cells from large follicles are sensitive only to IFN-a (Spicer and Alpizar, 1994) . Thus, cytokines seem to suppress differentiation of granulosa cells, and less differentiated cells are more sensitive to the effects of cytokines than are more differentiated cells. There is some evidence that cytokines, particularly IL-113, may be involved in the ovulatory process. Periovulatory ovine follicles secrete a chemoattractant for leukocytes (Murdoch and McCormick, 1989) , and the ovulation rate of perfused rat ovaries is enhanced in the presence of leukocytes (Hellberg et al., 1991) . Brannstrom et al. (1993a) reported that IL-113 can cause ovulation in the rat ovary perfused in vitro, and greatly enhances the LH-induced ovulation rate. The potential role of cytokines in ovulation has recently been reviewed by Brannstrom and Norman (1993) . Very little is known about the role of cytokines in luteinization and early luteal function, although leukocytes are often involved in tissue remodelling events, which occur at this time (Smith et al., 1994) .
In sheep, large numbers of eosinophils, but small numbers of neutrophils and lymphocytes were found in the developing corpus luteum (Cavender and Murdoch, 1988) . Progesterone synthesis is enhanced by TNF-a in rat thecal (Roby and Terranova, 1990; Brannstrom et al., 1993b) and human luteinized granulosa (Yan et al., 1993) cells, and by IL-113 in hamster thecal cells (Nakamura ef al., 1990) . Yan et al. (1993) proposed that TNF-ct promotes formation of the corpus luteum by increasing proliferation and steroidogenesis of luteinizing granulosa cells. Again, the effects of cytokines may depend on the state of differentiation of the target cell as well as the presence or absence of other growth factors and regulators of the differentiative process.
If cytokines play a role in follicular or luteal function, it is a prerequisite that they be present in the tissue. Immunoreactive TNF-a has been identified in the follicular and luteal compartments of the bovine ovary and is secreted by granulosa cells (Roby and Terranova, 1989) . Ji et al. (1991) detected TNF-a mRNA and bioactivity in regressing ovine corpora lutea, but only after the initial fall in progesterone. Preliminary observations in our laboratory indicate that mRNA encoding TNF-a is present in the bovine corpus luteum before luteolysis. The ovary is also a source of IL-1 and GM-CSF (Ziltener et al., 1993; Brannstrom et al., 1994b) .
Role of Immune Cells and Cytokines in Luteolysis
Most of the work in ruminants on immune cell and cytokine effects on the ovary has concerned their potential role in luteal regression. As mentioned previously, leukocytes are present in the corpus luteum or infiltrate the tissue at about the time of luteolysis. Clearly, these cells are actively involved in the destruction of luteal cells after they are no longer functional. Recently, however, it has been suggested that immune cells or cytokines may be involved in functional changes that are associated with luteal regression. The first indication that an intact immune system may be necessary for normal cyclic ovarian function was the inhibition of ovulation and the development of a constant dioestrus in rats treated with antithymocyte serum (Bukovsky et al., 1977) . It is likely that the effects of the immune system are mediated by alterations of the hypothalamo-pituitary-gonadal axis, as well as through direct interactions with ovarian cells.
We have used primary cultures of bovine luteal cells to determine whether cytokines could directly influence luteal cell functions. These cells were all maintained in serum-free culture medium supplemented with insulin, transferrin and selenium. In an initial study, we reported that IL-113 did not significantly affect basal progesterone production by luteal cells (Nothnick and Pate, 1990) . However, in subsequent experiments, we found that IL-113 does inhibit LH-stimulated steroidogenesis ( Fig. 1) . Pitzel et al. (1993) reported that IL-I decreased both basal and LH-stimulated progesterone in pig luteal cells.
The different effects of IL-I on basal progesterone in these two studies could be due to the presence of serum in the porcine cell cultures, which may have provided additional growth factors or hormones which were antagonized by IL-1. The most profound effect of IL-I13 that was observed in bovine luteal cell cultures was the stimulation of prostaglandin synthesis. Treatment with IL-113 resulted in large, Values are means ± sem (n= 8 corpora lutea). *Significantly different from control (Student's t-test, P <0.01).
dose-dependent increases in PGF,", PGE, and 6-keto-PGF1, (the stable metabolite of prostacyclin). This stimulatory effect of IL-4 was completely blocked by indomethacin (Nothnick and Pate, 1990), cycloheximide or actinomycin D (Townson and Pate, 1994) . The acute (6 h) stimulation of luteal prostaglandin production by IL-113 appears to be via activation of phospholipase A2, and to a lesser extent, phospholipase C. Thus, a primary action of IL-1f3 is to increase availability of arachidonic acid for conversion to prostaglandins.
After chronic (72 h) exposure to IL-113, luteal cells exhibit an enhanced ability to convert exogenous arachidonic acid to PGF,", suggesting an upregulation of prostaglandin synthase (PGS) (Townson and Pate, 1994) .
The actions of TNF-u on bovine luteal cells are very similar to those of IL-1f3. Gonadotrophinstimulated steroidogenesis is suppressed and prostaglandin synthesis is stimulated by TNF-u. (Benyo and Pate, 1992 When combined, TNF-u and IL-1f3 exert synergistic effects on luteal prostaglandin production (Benyo and Pate, 1992) . TNF-o. inhibits basal and gonadotrophin-stimulated progesterone secretion, and enhances the inhibitory effects of PGF," and oxytocin in pig luteal cells (Pitzel et al., 1993) . Therefore, all of the known effects of TNF-a on fully differentiated luteal cells are consistent with a role for this cytokine in luteal regression.
Another cytokine that is thought to be involved in luteolysis is IFN-y. This cytokine exerts biphasic effects on cultured bovine luteal cells. During the first 24 h of culture, IFN-y has no effect on progesterone synthesis but inhibits prostaglandin production. After 72 h, no difference is observed in either progesterone or prostaglandin secretion compared with control cells. However, after this time, IFN-y completely inhibits LH-stimulated progesterone and markedly stimulates prostaglandin synthesis by these cells (Fairchild and Pate, 1991) . Since PGF, is known to inhibit LH-stimulated progesterone production in luteal cells in vitro (Pate and Condon, 1984) , it was assumed that the inhibition of steroidogenesis by IFN-y was due to its stimulation of endogenous PGF". This possibility was tested by culturing luteal cells in the presence of indomethacin, at a concentration that completely prevented the IFN-y-induced increase in prostaglandins.
The assumption proved to be incorrect, because IFN-y was equally effective at inhibiting LH-stimulated progesterone in the presence or absence of indomethacin ( Fig. 2 ; Fairchild and Pate, 1991) . Therefore, the ability of IFN-7 to inhibit gonadotrophin-stimulated steroidogenesis does not depend on the increase in endogenous prostaglandins.
Interactions betweencytokines, lutealprostaglandins and progesterone
If the stimulation of prostaglandin synthesis is not responsible for the inhibition of progesterone, then a question arises regarding the role of luteal prostaglandins.
This question has been difficult to address using models in vivo because of the many systemic effects of prostaglandins and the requirement for uterine PGF," to initiate luteolysis. Cultured luteal cells also may not be an appropriate model to study this problem, because luteal prostaglandins may act on other cell types. Prostaglandins are known to be potent vasodilators or vasoconstrictors.
The ability of PGF," to decrease blood flow to the corpus luteum at the time of luteolysis has been studied (reviewed by Wiltbank, 1994) . It is possible that uterine PGF,c, causes the initial fall in progesterone by acting directly on luteal cells, and luteal prostaglandins are then released which act on capillary endothelial cells to regulate blood flow. Another likely role for luteal prostaglandins is to alter the local immune response. Prostaglandins can modulate activation of immune cells and cytokine secretion. It is possible that immune cells within the corpus luteum must be exposed to prostaglandins to become activated and facilitate luteolysis. Macrophages will infiltrate a fully functional corpus luteum that has received an implant, but will remain in the corpus luteum only if PGF," is present to cause luteolysis (Hehnke et al., 1994) . Although prostaglandins are generally thought to be proinflammatory compounds they can also suppress an immune response (Goodwin and Webb, 1980) . Luteal prostaglandins may act to enhance the function of immune cells to promote luteal regression or modify the local immune response so that it does not extend into the surrounding ovarian tissues.
Although endogenous prostaglandins may not be directly involved in the inhibition of steroidogenesis, progesterone may modify cytokine-stimulated prostaglandin production. When cultured luteal cells are deprived of an exogenous source of cholesterol (such as lipoprotein), progesterone synthesis will decline with time in culture. If exogenous progesterone is added to the cultures to maintain progesterone concentrations equivalent to day 1, it is possible to study the function of cells in a low (control) or normal (progesterone-supplemented) steroid environment. In this situation, progesterone suppresses basal prostaglandin production by luteal cells. More importantly, the high concentrations of progesterone inhibit IL-1f3-, IFN-y-and TNF-a-stimulated prostaglandin production (Fig. 3) . It is well known that gonadal steroids are important modulators of the immune response, and progesterone is usually immunosuppressive.
In addition to direct suppression of immune cell activation, high local concentrations of progesterone may also suppress responsiveness of target cells to cytokines. This could explain why cultured luteal cells are more responsive to IFN-y later in culture. In addition, the action of cytokines on luteal cells in vivo may be suppressed when the corpus luteum is fully functional. When progesterone concentrations begin to decline, this suppression would be released, allowing luteal cells to become responsive to cytokines. This hypothesis is currently being tested in our laboratory.
Cytotoxic actions of cytokineson lutealcells
Certain cytokines also have direct cytotoxic effects on cells. Tumour necrosis factor was named for its ability to induce haemorrhagic necrosis of tumours. However, it does not generally cause cytolysis of normal cells. Although IL-I is not usually a cytotoxic agent, it can be cytotoxic to ovarian cells in culture (Ellman et al., 1993) . In bovine luteal cells, neither IL-0 nor TNF-cc affect cell viability when used alone (Nothnick and Pate, 1990; Benyo and Pate, 1992) . Some loss of cell viability does occur when cells are treated with IFN-y (Fairchild and Pate, 1991; Benyo and Pate, 1992) . However, marked cytotoxic effects were observed when TNF-a, and IFN-y were used together ( Fig. 4 ; Benyo and Pate, 1992) . The combination of TNF-a and IFN-y is also cytotoxic to pancreatic 13-islet cells (Campbell et al., 1988) enhanced by IFN-y (Dealtry et a) ., 1987). Both of these cytokines enhance expression of receptors for the other cytokine, which could explain why both are necessary to achieve a substantial cytotoxic effect in many types of cell.
The mechanisms by which TNF-a and IFN-y exert cytotoxic effects on luteal cells are not known. In some ovarian cells, IL-113 is cytotoxic, and its effects appear to be mediated by nitric oxide (Ellman et al., 1993) , 1991) . During luteolysis in rats, there is an increase in superoxide radicals and hydrogen peroxide, and hydrogen peroxide inhibits cholesterol transport and gonadotrophin-stimulated steroidogenesis in rat luteal cells (reviewed by Behrman et a)., 1993). Behrman et al. (1993) presented a model in which reactive oxygen species are intimately involved in luteolysis. Although the effects of reactive oxygen species on progesterone production are not due to cytotoxicity, it is possible that chronic exposure of luteal cells to H202 or 02 in the presence of cytokines results in eventual membrane damage and cell death. At this time, the mechanisms by which cytokines induce functional changes in luteal cells are at least partly known, but the mediators of their cytotoxic actions have remained elusive. A summary of the effects of cytokines on luteal cells is presented in Fig. 5. TNF-a, IFN-y,, IL-113 
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Activation of Immune Cells in Luteolysis
If immune cells and their secreted products are involved in luteal regression, there must be a trigger that activates the immune cells. As mentioned previously, T cells are activated by recognition of an MHC-associated antigenic peptide and exposure to sufficient concentrations of appropriate cytokines. Nearly all nucleated cells express MHC class I glycoproteins, which are recognized by cytotoxic T cells. MHC class II molecules are recognized by TH cells, which secrete cytokines that activate Tc cells. MHC class II molecules are normally expressed only on antigen-presenting cells, such as macrophages and B cells. However, aberrant expression of MHC class II molecules can occur in pathogenesis, and may be an underlying cause in certain autoimmune endocrine disorders (Bottazzo et al., 1983) . We suggested that the trigger for an immune response in luteolysis might be an alteration in, or aberrant expression of, MHC glycoproteins on the luteal cell surface. Cultured bovine luteal cells were used to determine that luteal cells did express MHC class I molecules, as expected, and there was very little expression of MHC class II molecules. Treatment with either TNF-a or IFNI/ for 72 h resulted in a slight, but significant, increase in MHC class I glycoproteins (Fairchild and Pate, 1991; Benyo and Pate, 1992) . High class I expression could promote cytotoxic T cell actions against luteal cells. Of greater interest was the profound induction of MHC class II molecules on luteal cells by IFN-7 (Fairchild and Pate, 1989) . This could allow for autoantigen recognition by helper T cells and stimulation of cytokine production. In the Each value represents the mean ± SEM (n = 4 corpora lutea per group). *Significant differences within cell populations between nonpregnant and pregnant animals. (Reproduced with permission from Benyo et al., 1991.) same study, stimulation of luteal cells with LH resulted in a slight, but significant, suppression of IFN-y-induced expression of MHC class II glycoproteins.
The potential relevance of expression of MHC molecules on bovine luteal cells was evaluated using freshly dispersed luteal cells from corpora lutea collected at three stages of the oestrous cycle. There were no observable changes in expression of class I glycoproteins throughout the lifespan of the corpus luteum. In the early corpus luteum (day 6), expression of MHC class II molecules was low. However, by day 10, nearly 80% of the large, less dense luteal cells displayed class II glycoproteins.
Small luteal cells exhibited increased expression by day 18 of the oestrous cycle. Increased expression was also observed in small and large luteal cells during PGF,"-induced luteolysis (Benyo et al., 1991) . Similar patterns of expression have also been observed in the sheep corpus luteum during the oestrous cycle (Kenny et al., 1991) , supporting the notion that these glycoproteins have a functional significance in regulation of the corpus luteum of ruminants. In human ovaries, an MHC class II protein was present on granulosa cells of atretic follicles and on luteinizing granulosa cells (Fujiwara et al., 1993) , and these authors concluded that this molecule may serve as a marker for differentiation of ovarian cells.
It is presumed that expression of MHC class II glycoproteins on the surface of luteal cells confers the function of antigen presentation to these cells. If this is the case, luteal cells would present an autoantigen to T cells, which could result in an immune response against the corpus luteum. The presence or identity of an autoantigen presented by luteal cells remains to be determined. Expression of MHC class II molecules on luteal cells may also activate different components of the immune system than is typically observed. In epithelial cells, expression of MHC class II molecules may activate cytotoxic T cells rather than helper T cells (Bland, 1988 Hsu and Olefsky, 1993) . It has also been suggested that the MHC molecules expressed by epithelial cells are present in a different conformation from those expressed on conventional antigen-presenting cells, which may be an indication of a distinct function for these molecules (Vidal ef a) ., 1993).
If immune cells are involved in the luteolytic process, it would be necessary for this immune response to be suppressed during maternal recognition of pregnancy. Certainly, alterations in normal immune response mechanisms occur in the placenta to allow for survival of the fetal allograft. It is possible that an immunological process involved in luteolysis would be altered concurrently with the establishment of pregnancy. This hypothesis is supported by the observations that infiltration of lymphocytes and macrophages in the bovine (Lobel and Levy, 1968) and rabbit (Bagavandoss et al., 1990) corpus luteum of pregnancy does not occur to the same extent as in the corpus luteum of the oestrous cycle. In addition, expression of MHC class II glycoproteins is significantly decreased on all luteal cell populations in pregnant compared with nonpregnant cows ( TH1 cells can produce interleukin-2 (IL-2), gamma-interferon (IFN-7) and tumour necrosis factor a (TNF-a). Cytokines can also be produced by TH2 and T, cells, but are not shown here. Activation of TH and Tc cells is further enhanced by IL-2. Resident macrophages, which may be activated by IFN-7, secrete IL-113 and TNE-a. Cytokines can act directly to affect luteal cell function. Progesterone production is suppressed by IFN-7, TINF-a and IL-113. In addition, these cytokines stimulate prostaglandin production by luteal cells, which may, in turn, act directly on luteal cells or immune cells. Finally, IFN-7 and TNIF-ce exert cytotoxic effects on luteal cells. Cell death may also be brought about by the actions of Tc or T5,1 cells, and dead cells are phagocytozed by activated macrophages.
Conclusions
Considerable evidence is accumulating that cytokines can exert functional and cytotoxic effects on luteal cells. Furthermore, immune cells are present in the corpus luteum before luteolysis and some cy tokines have been detected within luteal tissue. However, the exact role of immune cells and cytokines in luteal regression is still not clear. Treating rabbits with methylprednisolone to deplete luteal T cells and macrophages did not prevent the normal decline in progesterone at the end of pseudopregnancy (Seiner ef al., 1992) . In contrast, treating rats with dexamethasone did block luteolysis, in uterine-intact and in hysterectomized animals (Wang et al., 1993) . Experiments in vivo that can test the role of immune cells in luteolysis have not been performed in ruminants. In addition, it has been difficult to evaluate the presence of cytokines in ovarian tissues, because not all available assays crossreact with the ruminant proteins. Some cytokines, such as interferons, are highly species specific with regard to both their immunoreactivity and biological activity. The evidence from models in vitro and some experiments in vivo has provided a framework for the interactions of immune cells with luteal cells. These are shown in Fig. 8 . The functional significance of immune cells and cytokines in Hsu D and Olefsky JM (1993) Effect of a major histocompati
